Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 48Squamous Cell Carcinoma of Head and Neck 23Lung Neoplasms 22Oropharyngeal Neoplasms 13Urinary Bladder Neoplasms 12Nasopharyngeal Carcinoma 12Carcinoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 10Uterine Cervical Neoplasms 7Biliary Tract Neoplasms 7Pancreatic Neoplasms 6Neoplasms 6Head and Neck Neoplasms 6Esophageal Squamous Cell Carcinoma 6Endometrial Neoplasms 6Colorectal Neoplasms 6Cholangiocarcinoma 6Small Cell Lung Carcinoma 5Neoplasm Metastasis 5Mouth Neoplasms 5Stomach Neoplasms 4Laryngeal Neoplasms 4Esophageal Neoplasms 4Carcinoma, Squamous Cell 4Ovarian Neoplasms 3Neoplasms by Site 3Mesothelioma, Malignant 3Lymphoid Interstitial Pneumonia 3Hypopharyngeal Neoplasms 3Gallbladder Neoplasms 3

Interventions

pembrolizumab 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Solid Tumor × Cisplatin × 30 days × Clear all
NCT06057038 2026-06-02

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Genmab

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡